S. 3566 (112th): Recalcitrant Cancer Research Act of 2012

Introduced:
Sep 19, 2012 (112th Congress, 2011–2013)
Status:
Died (Reported by Committee)
Sponsor
Thomas “Tom” Harkin
Junior Senator from Iowa
Party
Democrat
Text
Read Text »
Last Updated
Sep 19, 2012
Length
10 pages
Related Bills
S. 3560 (identical)

Referred to Committee
Last Action: Sep 19, 2012

H.R. 733 (Related)
Recalcitrant Cancer Research Act of 2012

Passed House
Last Action: Sep 19, 2012

 
Status

This bill was introduced on September 19, 2012, in a previous session of Congress, but was not enacted.

Progress
Introduced Sep 19, 2012
Reported by Committee Sep 19, 2012
 
Full Title

An original bill to provide for scientific frameworks with respect to recalcitrant cancers.

Summary

No summaries available.

Cosponsors
none
Committees

Senate Health, Education, Labor, and Pensions

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

S. stands for Senate bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


9/19/2012--Reported to Senate without amendment.
Recalcitrant Cancer Research Act of 2012 - Amends the Public Health Service Act to require the Director of the National Cancer Institute (NCI) to develop a scientific framework for research on recalcitrant cancers (cancer with a 5-year relative survival rate below 50%), which includes:
(1) a review of the status of research, such as a summary of findings, identification of promising scientific advances, a description of the availability of qualified scientific researchers, and the identification of resources available to facilitate research;
(2) identification of research questions that have not been adequately addressed; and
(3) recommendations for actions to advance research and for appropriate benchmarks to measure progress on achieving such actions.
Requires the Director to develop the framework within 18 months and review and update it every 5 years.
Requires the Director to identify within 6 months 2 or more recalcitrant cancers that have a 5-year relative survival rate of less than 20%, and are estimated to cause the death of at least 30,000 individuals in the United States per year. Authorizes the Director to identify additional such cancers and to consider additional metrics of progress (such as incidence and mortality rates) against such cancer.
Requires the Director to convene a working group for each identified cancer to provide expertise on, and assist in developing, a scientific framework under this Act.
Requires the Director to consider each relevant scientific framework developed under this Act when making recommendations for exception funding for grant applications.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of S. 3566 (112th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus